Cancer is a leading cause of global death. Medicinal plants have gained increasing attention in cancer drug discovery. In this study, the stem bark extract of , which is used in ethnomedicine to treat cancer, was subjected to phytochemical investigation leading to the isolation of oleanolic acid (OA).
View Article and Find Full Text PDFBackground: β-ketoacyl-ACP synthase I (KasA I) enzyme is crucial in mycolic acid synthesis catalytic condensation reactions, hence implicated in 's virulence and drug resistance. Presently, there is no known potent KasA inhibitor; thiolactomycin lacks potency. Recently reported indazole compounds JSF-3285/DG167 and 5G/DG167 inhibit the KasA through binding to the substrate cavity.
View Article and Find Full Text PDFMultidrug resistance is a significant drawback in malaria treatment, and mutations in the active sites of the many critical antimalarial drug targets have remained challenging. Therefore, this has necessitated the global search for new drugs with new mechanisms of action. Plasmodium falciparum lactate dehydrogenase (pfLHD), a glycolytic enzyme, has emerged as a potential target for developing new drugs due to the parasite reliance on glycolysis for energy.
View Article and Find Full Text PDFEthnopharmacological Relevance: Combretum racemosum showed activity in previous ethnopharmacological investigations of some Combretum species used in malaria treatment in parts of West Africa.
Aim Of The Study: This study aimed at confirming the antimalarial potential of this plant by an activity-guided isolation of its active principles.
Materials And Methods: A crude methanolic leaf extract of Combretum racemosum and fractions thereof obtained by partition with chloroform and n-butanol were investigated for antiplasmodial activity against chloroquine-sensitive (D10) and chloroquine-resistant (W2) strains of Plasmodium falciparum.